U.S. Markets open in 51 hrs, 5 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
| Day Low | 11.04 03:33 PM EDT | |
|---|---|---|
| Day High | 11.62 09:32 AM EDT |
|
| Range | 0.58 |
| Volume | 106,781 | |
|---|---|---|
| 30-Day Avg Vol | 156,000 |
|
| Difference | -31.55% |
| Market Cap | 315.69 M | |
|---|---|---|
| Mkt Cap Chg | -13.49 M |
| Shares Out | 28.11 M | |
|---|---|---|
| % Shrs Traded | 0.38% | |
| 1yr EPS Est | -1.575 |
| 52-Wk Low | 7.62 3/12/09 | |
|---|---|---|
| 52-Wk High | 24.68 8/5/08 |
|
| Range | 17.06 |
| Prev Close | 11.71 7/1/09 | |
|---|---|---|
| Today's Open | 11.59 | |
| Change | -1.02% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 2 M |
| Revenue (LFY) | 1.85 M | |
|---|---|---|
| Earnings (LFY) | -54.66 M | |
| Earnings (MRQ) | -15.47 M | |
| Next Earn Est | -0.375 | |
| Next Earnings | 08/14/2009 |
|
| EPS (TTM) | -2.73 | |
| 1yr EPS Growth | 42.52% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -7.00 | |
| PEG Ratio | -0.35 | |
| Return on Equity | -177.58 | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more infoPharmasset uses its intellectual capital to take down the viruses that take down people's defenses. The company develops and plans to commercialize oral anti-viral drugs based on its nucleoside analog ... View Full Description

| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.375 8/14/09 | — — |
—
—
|
| Last Quarter | -0.475 3/31/09 | -0.59 3/31/09 |
-0.115
Missed
|
| 2 Quarters Ago | -0.515 12/31/08 | -0.78 12/31/08 |
-0.265
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 1.90 M | 1.86 M |
| Gross Profit | 215,221.00 | 861,921.00 |
| Operating Income | -14.69 M | -54.43 M |
| Net Income | -15.47 M | -54.66 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.